Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,095 | 2,109 | 1,264 | 1,644 | 2,011 |
| Operating Income | -2,095 | -2,109 | -1,264 | -1,644 | -2,011 |
| Other Income | 203 | -386 | 160 | -1,565 | 97 |
| Pre-tax Income | -1,892 | -2,495 | -1,104 | -3,209 | -1,914 |
| Net Income Continuous | -1,892 | -2,495 | -1,104 | -3,209 | -1,914 |
| Net Income | $-1,892 | $-2,495 | $-1,104 | $-3,209 | $-1,914 |
| EPS Basic Total Ops | -0.33 | -0.63 | -0.62 | -2.02 | -2.31 |
| EPS Basic Continuous Ops | -0.35 | -0.63 | -0.62 | -2.02 | -2.31 |
| EPS Diluted Total Ops | -0.33 | -0.63 | -0.62 | -2.02 | -2.31 |
| EPS Diluted Continuous Ops | -0.35 | -0.63 | -0.62 | -2.02 | -2.31 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.63 | -0.62 | N/A | -2.31 |
| EBITDA(a) | $-2,090 | $-2,127 | $-1,230 | $-1,661 | $-2,011 |